Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes.
Dirk Müller-WielandMonika KellererKatarzyna CyprykDasa SkripovaKatja RohwedderEva JohnssonRicardo Garcia-SanchezRaisa KurlyandskayaC David SjöströmStephan JacobJochen SeufertNalina DronamrajuKatalin CsomósPublished in: Diabetes, obesity & metabolism (2018)
Dapagliflozin, saxagliptin and metformin improved glycaemic control compared with glimepiride plus metformin; add-on of dapagliflozin alone showed efficacy similar to that of glimepiride. Both dapagliflozin regimens decreased body weight and SBP, with a lower incidence of hypoglycaemia compared with glimepiride.
Keyphrases